KRAS and neoplasm: In our findings, a number of PDAC organoids displaying metastatic potency (MP) presented with variant allele frequencies (VAFs) exceeding 0.5 for the c.35G > A mutation in KRAS, suggesting that this mutation may play a prominent role within the tumor’s clonal hierarchy at the time of surgical resection.